Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

AZN

AstraZeneca (AZN)

AstraZeneca PLC

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 35 36 37 38 39 40 41 42 43 44 45

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
10/10/2005	11h33	PR Newswire (US)	Global Survey Released on the World Mental Health Day 2005 Emphasizes Treatment Needs in Bipolar Disorder	NYSE:AZN
08/08/2005	00h58	PR Newswire (US)	The Children's Hospital Receives $50,000 Donation Through The CRESTOR(R) Charity Challenge at PGA TOUR's The INTERNATIONAL	NYSE:AZN
11/06/2005	19h30	PR Newswire (US)	Phase II Trial of GALIDA(TM) (tesaglitazar) Evaluates Glucose and Lipid Abnormalities in Type 2 Diabetes Patients	NYSE:AZN
24/05/2005	03h32	PR Newswire (US)	CRESTOR Safe and Effective When Used According to Prescribing Information	NYSE:AZN
24/04/2005	23h00	PR Newswire (US)	New Study on Effects of CRESTOR on Carotid Atherosclerosis Presented at European Atherosclerosis Society Congress	NYSE:AZN
24/04/2005	21h00	PR Newswire (US)	New Data Demonstrates the Efficacy of CRESTOR(R) Compared to Other Leading Statins in Treating High-Risk Patient Populations For	NYSE:AZN
05/04/2005	14h30	PR Newswire (US)	AstraZeneca Strengthens Commitment to Provide Free and Low-Cost Medicines to Patients in Need Through New Industry Initiative	NYSE:AZN
04/04/2005	08h42	PR Newswire (US)	'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend Life in Prostate Cancer Patients	NYSE:AZN
04/04/2005	02h01	PR Newswire (US)	'Zoladex(R)' (Goserelin) Adjuvant to Radiotherapy Found to Extend Life in Prostate Cancer Patients	NYSE:AZN
16/11/2004	00h00	PR Newswire (US)	New ASCO Recommendation for Postmenopausal Women With Early Breast Cancer	NYSE:AZN
09/11/2004	16h15	PR Newswire (US)	AstraZeneca Presents New Data for CRESTOR(R) in African-American Patients with High Cholesterol at American Heart Association An	NYSE:AZN
11/09/2004	03h10	PR Newswire (US)	/C O R R E C T I O N -- AstraZeneca/	NYSE:AZN
08/07/2004	16h40	PR Newswire (US)	SkyePharma and AstraZeneca Announce Completion of Phase III Trials of HFA-MDI Version of Pulmicort(R)	NYSE:AZN
06/06/2004	22h14	PR Newswire (US)	Final Results For IRESSA(R) (gefitinib) Tablets Reported From Compassionate Use Program in Non-Small-Cell Lung Cancer Patients	NYSE:AZN
05/06/2004	16h20	PR Newswire (US)	New IRESSA(R) (Gefitinib) Data Presented in Bronchioalveolar Lung Cancer	NYSE:AZN
05/05/2004	23h00	PR Newswire (US)	New Data Presented at the American Psychiatric Association Annual Meeting May Shape the Standard of Care for Bipolar Disorder	NYSE:AZN

Showing the most relevant articles for your search:NASDAQ:AZN

<< Previous 35 36 37 38 39 40 41 42 43 44 45

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen